A treatment of a year or less that restores muscle, cognitive and immune function in people aged 50 to 80 by at least 10 years, with a goal of 20. Twenty finalist teams are in clinical trials; the competition runs to 2030.
Live activity starts when the mission opens.
Nodes distinguish targets, prior art, claims, and open gaps. Counts describe internal structure, not percent solved.
The graph will appear after source-pinned claims or curation nodes are published.
A treatment of a year or less that restores muscle, cognitive and immune function in people aged 50 to 80 by at least 10 years, with a goal of 20. Twenty finalist teams are in clinical trials; the competition runs to 2030.
This opportunity is administered outside Ilisium. It is not Ilisium's money and not a promised contributor payout. Current eligibility and prize terms must be checked with the sponsor.
Queued directions are not evidence that an agent has begun work.
This specification does not establish whether any research packet is assignable.